Fosinopril vs lisinopril
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Comparative Analysis of Fosinopril and Lisinopril
Pharmacokinetics and Accumulation in Renal Insufficiency
Pharmacokinetics of Fosinopril and Lisinopril
Fosinopril and lisinopril are both angiotensin-converting enzyme (ACE) inhibitors used to manage conditions such as hypertension and heart failure. However, they exhibit distinct pharmacokinetic profiles, particularly in patients with renal insufficiency. Fosinopril is a phosphinyl ester prodrug that is hydrolyzed to its active form, fosinoprilat, which is eliminated via both renal and hepatic routes. This dual elimination pathway allows fosinopril to have less accumulation in patients with renal insufficiency compared to lisinopril, which is primarily eliminated by the kidneys .
Accumulation Indices
Studies have shown that fosinoprilat has a significantly lower accumulation index (AI) compared to lisinopril in patients with chronic renal insufficiency. For instance, the AI for fosinoprilat was found to be 1.21, whereas for lisinopril it was 2.76, indicating a higher accumulation of lisinopril in the body over time . This reduced accumulation of fosinoprilat is beneficial in minimizing the risk of concentration-related adverse events in patients with compromised renal function .
Blood Pressure and Renal Hemodynamics
Blood Pressure Control
Both fosinopril and lisinopril are effective in lowering blood pressure in hypertensive patients with chronic renal insufficiency. A study comparing the two drugs over a 22-week period found that both medications significantly reduced systolic and diastolic blood pressure to a similar extent in both black and nonblack patients. This indicates that both drugs are equally effective in managing hypertension in diverse patient populations.
Renal Hemodynamics
While both drugs effectively lower blood pressure, they exhibit different effects on renal hemodynamics. Fosinopril tends to have a more favorable impact on renal function, particularly in black patients, where it was observed to maintain or even improve glomerular filtration rate (GFR) over time, unlike lisinopril, which was associated with a significant decrease in GFR in the same patient group.
Therapeutic Efficacy in Heart Failure
Chronic Heart Failure Management
In patients with chronic heart failure (CHF) and preserved left ventricular ejection fraction, both fosinopril and lisinopril improve structural and functional heart parameters, reduce neurohumoral activity, and optimize blood pressure. However, fosinopril has been shown to have a more pronounced positive effect on regulatory adaptive status (RAS), exercise tolerance, and quality of life compared to lisinopril . This suggests that fosinopril may be preferable in managing CHF due to its broader benefits on overall cardiovascular health and patient well-being.
Cognitive Function and Memory
Cognitive Benefits
Interestingly, fosinopril has also demonstrated potential cognitive benefits. In a study involving scopolamine-induced amnesic rats, fosinopril significantly ameliorated memory deficits and hippocampal degeneration, indicating its possible role in preventing memory deficits seen in dementia. This antiamnesic activity was more pronounced with fosinopril compared to lisinopril, suggesting additional therapeutic advantages of fosinopril in cognitive health.
Safety and Tolerability
Lithium Toxicity
A notable safety consideration is the differential impact of these ACE inhibitors on lithium levels. A case study highlighted a significant increase in serum lithium levels and creatinine after switching from fosinopril to lisinopril, underscoring the need for diligent monitoring of lithium-treated patients when changing ACE inhibitors.
Blood Pressure Maintenance
When switching from lisinopril to fosinopril, maintaining equivalent blood pressure control can be challenging without adjusting the dose of fosinopril. A study found that while blood pressure goals were initially maintained, more aggressive targets were harder to achieve without increasing the fosinopril dose.
Conclusion
In summary, while both fosinopril and lisinopril are effective ACE inhibitors for managing hypertension and heart failure, fosinopril offers advantages in terms of lower accumulation in renal insufficiency, better renal hemodynamic response, and potential cognitive benefits. However, careful monitoring is required when switching between these medications, particularly in patients with concurrent lithium therapy.
Sources and full results
Most relevant research papers on this topic